Aggregate Safety Assessment Planning in Clinical Trial Drug Development: Survey of Clinical Safety Professionals and Safety Data Scientists Advancing Premarket Safety Analytics at 21 Companies.
- DOI
- 10.1007/s43441-026-01055-2
- Published
- 2026 Oct 15
- Container
- Therapeutic innovation & regulatory science
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-026-01055-2,
title = {Aggregate Safety Assessment Planning in Clinical Trial Drug Development: Survey of Clinical Safety Professionals and Safety Data Scientists Advancing Premarket Safety Analytics at 21 Companies.},
author = {Ball G and Mahoney S},
year = {2026},
journal = {Therapeutic innovation \& regulatory science},
doi = {10.1007/s43441-026-01055-2},
url = {https://doi.org/10.1007/s43441-026-01055-2}
}RIS
TY - JOUR TI - Aggregate Safety Assessment Planning in Clinical Trial Drug Development: Survey of Clinical Safety Professionals and Safety Data Scientists Advancing Premarket Safety Analytics at 21 Companies. AU - Ball G AU - Mahoney S PY - 2026 JO - Therapeutic innovation & regulatory science DO - 10.1007/s43441-026-01055-2 UR - https://doi.org/10.1007/s43441-026-01055-2 ER -
APA
G, B., & S, M. (2026). Aggregate Safety Assessment Planning in Clinical Trial Drug Development: Survey of Clinical Safety Professionals and Safety Data Scientists Advancing Premarket Safety Analytics at 21 Companies.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-026-01055-2
Source records
- pubmed · retrieved 2026-11-10T21:30:04.619Z